Headlines

Jazz Pharmaceuticals has agreed to pay $145 million to resolve antitrust litigation alleging pay-for-delay tactics with popular narcolepsy drug Xyrem®.

One study found that people with diabetes who take semaglutide are over four times more likely to be diagnosed with NAION than people with diabetes who had not been prescribed a GLP-1 RA drug like Ozempic®.

In the United States alone, as the result of their employment, 2.6 million workers suffer nonfatal injuries or illnesses each year. Another 5,000 workers in the United States die at work annually. Aware of staggering statistics like these, the AFL-CIO declared April 28 Workers’ Memorial Day in 1989.

Our client lost their livelihood after being diagnosed with nonarteritic anterior ischemic optic neuropathy (NAION). Despite stopping Ozempic, they remain legally blind.

A tourist helicopter lost control and plunged into the Hudson River on April 10, 2025, claiming the lives of a family of five and the pilot.

In 2024, the EPA took the long overdue action of banning chrysotile asbestos—the only form of asbestos currently known to be used or imported in the U.S.

A civil lawsuit has been filed in California federal court seeking to hold the Sinaloa Cartel and it's indicted drug kingpins responsible for the DEA special agent Kiki Camarena's brutal kidnap and murder in 1985.

Studies have linked talcum powder and ovarian cancer. Learn about the connection and related lawsuits here.

A federal lawsuit was filed today against Delta Air Lines, Inc., and its subsidiary Endeavor Air, following the crash landing of Delta Flight 4819 at Toronto Pearson International Airport on Feb. 17, 2025.

The Motley Rice Antitrust Practice Group continues to be recognized as one of the nation’s foremost plaintiffs’ antitrust class action practices.